vs
Side-by-side financial comparison of Dime Community Bancshares, Inc. (DCOM) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $123.8M, roughly 1.3× Dime Community Bancshares, Inc.). On growth, Dime Community Bancshares, Inc. posted the faster year-over-year revenue change (3040.1% vs -22.7%). Over the past eight quarters, Dime Community Bancshares, Inc.'s revenue compounded faster (22.9% CAGR vs -11.5%).
The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
DCOM vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $164.7M |
| Net Profit | — | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 38.6% | -43.3% |
| Net Margin | — | -82.0% |
| Revenue YoY | 3040.1% | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | $0.68 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $164.7M | ||
| Q3 25 | $115.6M | $211.0M | ||
| Q2 25 | $109.7M | $178.9M | ||
| Q1 25 | $103.8M | $1.2B | ||
| Q4 24 | $3.9M | $213.2M | ||
| Q3 24 | $87.6M | $196.8M | ||
| Q2 24 | $87.3M | $186.7M | ||
| Q1 24 | $82.0M | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $27.7M | $15.9M | ||
| Q2 25 | $29.7M | $-64.8M | ||
| Q1 25 | $21.5M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $13.3M | $-106.7M | ||
| Q2 24 | $18.5M | $-99.2M | ||
| Q1 24 | $17.7M | $-91.6M |
| Q4 25 | 38.6% | -43.3% | ||
| Q3 25 | 34.7% | 1.4% | ||
| Q2 25 | 36.6% | -19.5% | ||
| Q1 25 | 27.6% | 82.5% | ||
| Q4 24 | -433.6% | -76.2% | ||
| Q3 24 | 20.8% | -27.7% | ||
| Q2 24 | 29.8% | -21.5% | ||
| Q1 24 | 29.6% | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | 23.9% | 7.5% | ||
| Q2 25 | 27.1% | -36.3% | ||
| Q1 25 | 20.7% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 15.2% | -54.2% | ||
| Q2 24 | 21.2% | -53.1% | ||
| Q1 24 | 21.6% | -43.6% |
| Q4 25 | $0.68 | $-1.63 | ||
| Q3 25 | $0.59 | $0.20 | ||
| Q2 25 | $0.64 | $-0.83 | ||
| Q1 25 | $0.45 | $10.04 | ||
| Q4 24 | $-0.58 | $-0.85 | ||
| Q3 24 | $0.29 | $-1.39 | ||
| Q2 24 | $0.43 | $-1.29 | ||
| Q1 24 | $0.41 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $-205.3M |
| Total Assets | $15.3B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $1.5B | $-205.3M | ||
| Q3 25 | $1.5B | $-155.8M | ||
| Q2 25 | $1.4B | $-206.5M | ||
| Q1 25 | $1.4B | $-185.8M | ||
| Q4 24 | $1.4B | $-1.1B | ||
| Q3 24 | $1.3B | $-1.1B | ||
| Q2 24 | $1.3B | $-980.2M | ||
| Q1 24 | $1.2B | $-893.9M |
| Q4 25 | $15.3B | $2.9B | ||
| Q3 25 | $14.5B | $2.6B | ||
| Q2 25 | $14.2B | $2.6B | ||
| Q1 25 | $14.1B | $2.7B | ||
| Q4 24 | $14.4B | $1.7B | ||
| Q3 24 | $13.7B | $1.8B | ||
| Q2 24 | $13.5B | $1.9B | ||
| Q1 24 | $13.5B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $186.6M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $186.6M | $-34.3M | ||
| Q3 25 | $52.1M | $-66.3M | ||
| Q2 25 | $23.1M | $-58.3M | ||
| Q1 25 | $65.4M | $870.1M | ||
| Q4 24 | $99.1M | $-30.0M | ||
| Q3 24 | $-33.3M | $-77.0M | ||
| Q2 24 | $12.6M | $-71.5M | ||
| Q1 24 | $30.7M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | $51.2M | $-69.7M | ||
| Q2 25 | $20.4M | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | $-34.1M | $-77.5M | ||
| Q2 24 | $9.2M | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | 44.3% | -33.1% | ||
| Q2 25 | 18.6% | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | -38.9% | -39.4% | ||
| Q2 24 | 10.5% | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.7% | 1.6% | ||
| Q2 25 | 2.4% | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 3.9% | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | -4.17× | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
